Search Results

The IMAGEN™ Parainfluenza virus Group (Types 1, 2 and 3) is a qualitative direct immunofluorescence test for the presumptive detection and confirmation of parainfluenza virus type 1, 2 and 3 antigens in respiratory specimens (nasopharyngeal aspirates) from paediatric populations and in cell culture preparations. The IMAGEN™ Parainfluenza virus Types 1. 2 and 3 is a qualitative direct immunofluorescence test for the presumptive detection and differentiation of parainfluenza virus type 1, 2 and 3 antigens respectively in respiratory specimens (nasopharyngeal aspirates) from paediatric populations and in cell culture preparations. A negative result obtained following direct staining of nasopharyngeal aspirates should be considered presumptive until confirmed by culture.

IMAGEN™ Parainfluenza Virus Group (Types 1, 2 and 3) is for the detection and confirmation of the presence of Parainfluenza virus antigens in cell culture preparations and direct specimens (nasopharyngeal aspirates) from paediatric populations. A single reagent is provided which contains a mix of purified murine monoclonal antibodies specific to Parainfluenza virus types 1, 2 and 3, conjugated to fluorescein isothiocyanate (FITC). IMAGEN™ Parainfluenza Virus Types 1, 2 and 3 is for the detection and differentiation of Parainfluenza virus type 1, 2 and 3 antigens respectively in cell culture preparations and direct specimens (nasopharyngeal aspirates) from paediatric populations. Three individual reagents are provided which each contain a purified murine monoclonal antibody specific to either Parainfluenza virus type 1, 2 or 3, conjugated to fluorescein isothiocyanate (FITC). The technological characteristics of the IMAGEN ™ Parainfluenza Virus Group (Types 1, 2 and 3) and IMAGEN'''' Parainfluenza Virus Types 1, 2 and 3 differ from those of the Predicate Device in that they consist of directly FITC labelled type specific mouse monoclonal antibodies which are used in a one step direct immunofluorescence technique.